CIBC World Market’s Eupraxia Pharmaceuticals EPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding EPRX
CIBC World Market's EPRX Position: Q3 2026 in Review
CIBC World Market reduced its Eupraxia Pharmaceuticals (EPRX) stake by 6.8% in Q3 2026, selling an estimated $114K and leaving 218,677 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #884.
CIBC World Market first reported a position in EPRX in Q2 2025 and has held it in 6 quarters since. 70 funds tracked by Wall St. Rank hold EPRX as of Q3 2026.
- CIBC World Market held 218,677 shares of Eupraxia Pharmaceuticals worth $2M as of Q3 2026.
- CIBC World Market sold 15,996 Eupraxia Pharmaceuticals shares in Q3 2026, an estimated $114K.
- Eupraxia Pharmaceuticals made up ﹤0.01% of CIBC World Market's portfolio in Q3 2026, its #884 holding.
- CIBC World Market first reported a position in Eupraxia Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- 70 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q3 2026.
Based on CIBC World Market's 13F filing for Q3 2026, filed 10 Nov 2026.